M0249
HCPCSAdm tocilizu covid-19 1st
Official HCPCS Level II long descriptor
Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, first dose
HCPCS Level II code M0249 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Adm tocilizu covid-19 1st
Added to HCPCS: 2021-06-24
Nearby codes in M0
- M0231Inf tocilizumab-bavi 1st dos
- M0232Inf tocilizumab-bavi 2nd dos
- M0233Intra inf, toci, first dose
- M0234Intra inf, toci, second dos
- M0235Intrav inf, mon anti, fir do
- M0236Intrav inf, mon anti, sec do
- M0237Intrav inf, toci, first dose
- M0238Intrav inf, toci, second dos
- M0250Adm tocilizu covid-19 2nd
- M0300Iv chelationtherapy
- M0301Fabric wrapping of aneurysm
Where this code sits
Krasyn Codes for Chrome
Review coding suggestions beside a validated web workflow. Private pilot.
Request pilot accessSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.